Centrico Pharma Llp - Company Profile

It is a healthcare limited liability partnership based in Thane, Maharashtra, India, established in 2015.
2015 Thane, Maharashtra, India Active
Last Updated:
Access Report
About Centrico Pharma Llp

Centrico Pharma Llp, a active limited liability partnership, was established on 11 September 2015 in Thane, Maharashtra, India. Engaging in medical devices within the healthcare sector, it holds LLPIN: AAE-7464. Registered under ROC Roc Mumbai. It has total obligation of contribution of ₹0.10 M.

Its leadership includes Natrajan Ganesh Iyer (Designated Partner), Sweety Kumari Pushpraj Chopra (Designated Partner), Sangeeta Natrajan Iyer (Designated Partner). Its latest date of accounts and solvency statement 31 March 2021. It is based at Office No. 415, 4Th Floor, Jaydeep Emphasis, Plot No A/9, Midc Industrial Area,Thane, (West), Thane, Maharashtra, 400610.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    AAE-7464

  • Incorporation Date

    11 September 2015

  • Total Obligation of Contribution

    ₹0.10 M

  • ROC Code

    Roc Mumbai

  • Company Status

    Active

Key Metrics
  • Obligation of Contribution ₹ 0.10 M
  • Company Age 10 Year, 9 Months
  • Last Filing with ROC 31 Mar 2021
Company report

Centrico Pharma Llp

Company Report FY 2026-2027

Comprehensive Company Insights

Explore comprehensive insights into Centrico Pharma Llp — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Centrico Pharma Llp?
Current Designated Partners
Name Designation Appointment Date Status
Natrajan Ganesh Iyer Designated Partner 11 Sep 2015 Current
Sweety Kumari Pushpraj Chopra Designated Partner 11 Sep 2015 Current
Sangeeta Natrajan Iyer Designated Partner 11 Sep 2015 Current

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Centrico Pharma Llp.

Enhance accessibility to Centrico Pharma Llp's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.

Centrico Pharma Llp revenue growth over time
Centrico Pharma Llp profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
*******
*******
*******
*******
*******
Revenue from Operations
*******
*******
*******
*******
*******
*******
Total Assets
*******
*******
*******
*******
*******
*******
Profit or Loss
*******
*******
*******
*******
*******
*******
Net Worth
*******
*******
*******
*******
*******
*******
EBITDA
*******
*******
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Centrico Pharma Llp?

Unlock access to Centrico Pharma Llp's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

How Many Employees Work at Centrico Pharma Llp?

Unlock and access historical data on people associated with Centrico Pharma Llp, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Centrico Pharma Llp, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Centrico Pharma Llp's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Centrico Pharma Llp
Recent Activity within the Organization
  • Annual General Meeting

    The activity Centrico Pharma Llp last Annual general meeting of members was held on 31 Mar 2021 as per latest MCA records. was completed.

  • Statement of Assets & Liabilities

    Progress on Centrico Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Mumbai. was documented.

  • Director Appointment

    Progress on Natrajan Ganesh Iyer was appointed as a Designated Partner was appointed as a Designated Partner on 11 Sep 2015 & has been associated with this company since 10 years 9 months . was documented.

  • Director Appointment

    Progress on Sweety Kumari Pushpraj Chopra was appointed as a Designated Partner was appointed as a Designated Partner on 11 Sep 2015 & has been associated with this company since 10 years 9 months . was documented.

  • Director Appointment

    The activity Sangeeta Natrajan Iyer was appointed as a Designated Partner was appointed as a Designated Partner on 11 Sep 2015 & has been associated with this company since 10 years 9 months . was completed.

  • LLP Incorporation

    The activity Centrico Pharma Llp was registered on 11 Sep 2015 with Roc Mumbai & aged 10 years 9 months as per MCA records. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the LLPIN of Centrico Pharma Llp?

The LLPIN of Centrico Pharma Llp is AAE-7464.

Where is Centrico Pharma Llp headquartered?

Centrico Pharma Llp is headquartered at Office No. 415, 4Th Floor, Jaydeep Emphasis, Plot No A/9, Midc Industrial Area,Thane, (West), Thane, Maharashtra, 400610.

When was Centrico Pharma Llp incorporated?

Centrico Pharma Llp was incorporated on 11 September 2015.

Who are the current directors of Centrico Pharma Llp?

The current directors of Centrico Pharma Llp are

What is the primary industry of Centrico Pharma Llp?

The primary industry of Centrico Pharma Llp is Healthcare.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available